[The results of determining compatibility in the MLC reaction in hemoblastosis patients undergoing bone marrow transplantation from HLA-identical siblings].

Shpakova Ap, Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Dronova Vm, Bulycheva Ti, Okhrimenko Tn, Liubimova Ls
PubMed
May 1, 1993
Cited by 0

Related Papers

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59
Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells
|Leukemia|2015|53